China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial

Clinical Trial ◽

Myocardial Protection ◽

Multicenter Clinical Trial ◽

Double Blind ◽

Letter of comment on “Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial” (Am Heart J 2006;152:887.e9-14)

American Heart Journal ◽

10.1016/j.ahj.2007.01.015 ◽

2007 ◽

Vol 153 (5) ◽

pp. e25

Author(s):

Tom Vydt ◽

Pierfrancesco Agostoni

Keyword(s):

Myocardial Infarction ◽

Clinical Trial ◽

Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous Coronary ◽

No Reflow Phenomenon

GW25-e0235 Effects of Liraglutide on Glycemic Control and Left Ventricular Function in Patients with Acute Myocardial Infarction: a Randomized, Double-blind, Placebo-controlled Clinical Trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.06.611 ◽

2014 ◽

Vol 64 (16) ◽

pp. C132

Author(s):

Chen Weiren ◽

Yun-Dai Chen

Keyword(s):

Myocardial Infarction ◽

Clinical Trial ◽

Glycemic Control ◽

Left Ventricular Function ◽

Ventricular Function ◽

Left Ventricular ◽

Double Blind ◽

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial

BMJ Open ◽

10.1136/bmjopen-2016-011287 ◽

2016 ◽

Vol 6 (8) ◽

pp. e011287 ◽

Cited By ~ 2

Author(s):

José Tuñón ◽

Ignacio González-Hernández ◽

Lucía Llanos-Jiménez ◽

Joaquín Alonso-Martín ◽

Juan M Escudier-Villa ◽

...

Keyword(s):

Myocardial Infarction ◽

Clinical Trial ◽

Vitamin D ◽

Ventricular Remodelling ◽

Anterior Myocardial Infarction ◽

Double Blind ◽

Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial

American Heart Journal ◽

10.1016/j.ahj.2006.05.010 ◽

2006 ◽

Vol 152 (5) ◽

pp. 887.e9-887.e14 ◽

Cited By ~ 75

Author(s):

Guy Amit ◽

Carlos Cafri ◽

Sergei Yaroslavtsev ◽

Shmuel Fuchs ◽

Ora Paltiel ◽

...

Keyword(s):

Myocardial Infarction ◽

Clinical Trial ◽

Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous Coronary ◽

No Reflow Phenomenon

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13409136.14780164 ◽

2011 ◽

Author(s):

John Laffey ◽

Mairead Hayes

Keyword(s):

Myocardial Infarction ◽

Stem Cells ◽

Mesenchymal Stem Cells ◽

Dose Escalation ◽

Human Mesenchymal Stem Cells ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Adult Human

A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children

Medicine ◽

10.1097/md.0000000000023217 ◽

2020 ◽

Vol 99 (50) ◽

pp. e23217

Author(s):

Lina Wei ◽

Yina Guo ◽

Yutong Fei ◽

Lin Luo ◽

Caiwen Wang ◽

...

Keyword(s):

Clinical Trial ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Bacterial Pneumonia ◽

Efficacy And Safety ◽

Multicenter Clinical Trial ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

Yearbook of Cardiology ◽

10.1016/s0145-4145(10)79814-2 ◽

2010 ◽

Vol 2010 ◽

pp. 389-391 ◽

Cited By ~ 3

Author(s):

B.J. Gersh

Keyword(s):

Myocardial Infarction ◽

Stem Cells ◽

Mesenchymal Stem Cells ◽

Dose Escalation ◽

Human Mesenchymal Stem Cells ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Adult Human

Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study

Clinical Cardiology ◽

10.1002/clc.4960100610 ◽

1987 ◽

Vol 10 (6) ◽

pp. 351-356 ◽

Cited By ~ 53

Author(s):

H. S. Rasmussen ◽

M. Suenson ◽

P. Mcnair ◽

P. Nørregård ◽

S. Balslev

Keyword(s):

Myocardial Infarction ◽

Controlled Study ◽

Double Blind ◽

An Interim Report of A Double-Blind Placebo-Controlled Recanalisation Study of Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial Infarction

Drugs ◽

10.2165/00003495-198700333-00024 ◽

1987 ◽

Vol 33 (Supplement 3) ◽

pp. 146-150 ◽

Cited By ~ 4

Author(s):

Adam D. Timmis ◽

Brian Griffin ◽

Jonathan C.P. Crick ◽

John S. Flax ◽

Edgar Sowton

Keyword(s):

Myocardial Infarction ◽

Interim Report ◽

Double Blind ◽

Double Blind Placebo ◽

Activator Complex

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

Circulation ◽

10.1161/01.cir.69.4.740 ◽

1984 ◽

Vol 69 (4) ◽

pp. 740-747 ◽

Cited By ~ 187

Author(s):

J E Muller ◽

J Morrison ◽

P H Stone ◽

R E Rude ◽

B Rosner ◽

...

Keyword(s):

Myocardial Infarction ◽

Double Blind ◽